期刊
JOURNAL OF MOLECULAR ENDOCRINOLOGY
卷 58, 期 3, 页码 R191-R202出版社
BIOSCIENTIFICA LTD
DOI: 10.1530/JME-16-0253
关键词
GPR55; adipose tissue; diabetes II; cannabinoids
资金
- Ministerio de Economia y Competitividad [BFU2015-70664-R, BFU2014-55871]
- Xunta de Galicia [2016-PG057]
- Centro de Investigacion Biomedica en Red (CIBER) de Fisiopatologia de la Obesidad y Nutricion (CIBERobn), European Community [ERC-2011-StG-OBESITY53-281408]
- FEDER funds
- ISCIII/SERGAS
GPR55 is a G-protein-coupled receptor (GPCR) that has been identified as a new cannabinoid receptor. Given the wide localization of GPR55 in brain and peripheral tissues, this receptor has emerged as a regulator of multiple biological actions. Lysophosphatidylinositol (LPI) is generally accepted as the endogenous ligand of GPR55. In this review, we will focus on the role of GPR55 in energy balance and glucose metabolism. We will summarize its actions on feeding, nutrient partitioning, gastrointestinal motility and insulin secretion in preclinical models and the scarce data available in humans. The potential of GPR55 to become a new pharmaceutical target to treat obesity and type 2 diabetes, as well as the foreseeing difficulties are also discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据